Offline References

Razonable, Raymund, R., et.al. Division of Infectious Diseases and Internal Medicine, Mayo Clinic and Foundation, Selective Reactivation of Human Herpesvirus 6 variant A Occurs in Critically Ill Immunocompetent Hosts, The Journal of Infectious Diseases, January , 2002.
Dwyer JM. The use of antigen-specific transfer factor in the management of infections with herpes viruses. In: Kirkpatrick CH, Burger DR and Lawrence HS eds. Immunobiology of transfer factor. New York Academic Press 1983:233-243.
Viza D, Vich JM, Phillips J et al. Orally administered specific transfer factor for the treatment of herpesvirus infections. Lymphok Res 1985;4:27-30.
Jones JF, Jeter WS, Fulginiti VA et al. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Lancet 1981;2:122-124.
Ablashi DV, Levine PH, DeVinci C et al. Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy 1996;9:81-86.
Steele RW, Myers MG and Monroe VM. Transfer factor for the prevention of varicella-zoster infection in childhood. N Engl J Med 1980;303:355-359.
Lang I, Nekam H, Gergely P et al. Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol and Immunopathol 1982;25:139-144.
Boucheix C, Phillips J, Pizza G et al. Activity of animal transfer factor in man. Lancet 1977;1:198-199.
Fudenberg H and Pizza G. Transfer factor 1993: New frontiers. Progress in Drug Res 1994;42:309-400.
Arala-Chaves M, Ramos MTF and Rosado RMF. Evidence for prompt and intense constitution of cell-mediated immunity by means of transfer factor in a case of complex immune deficiency. Cell. Immunol. 1974;12:160.
Ballow M and Good RA. Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor. Cell. Immunol. 1975;19:219.
Jones JF, Pizza G, DeVinci C. Infectious mononucleosis: immunotherapy with EBV-specific transfer factor. J Exp Pathol 1987;3:399-406.
Khan A, Hansen B, Hill NO et al. Transfer factor in the treatment of herpes simplex types 1 and 2. Dermatologica 1981;163:177-185.
Winkelman RK, DeRemee RA, Ritts RE Jr. Treatment of varicella-zoster pneumonia with transfer factor. Cutis 1984;34:278-281.
Rozzo SJ and Kirkpatrick CH. Purification of transfer factors. Mol Immunol 1992;29:167-182.
Pizza G, Viza D, Roda A et al. Transfer factor for the treatment of chronic active hepatitis. N Engl J Med 1979;300:1332.
Nkrumah F, Pizza G, Viza D et al. Regression of progressive lymphadenopathy in a young child with acute cytomegalovirus (CMV) infection following the administration with specific anti-CMV activity. Lymphok Res 1985;4:237-241.
Neequaye J, Viza D, Levine PH et al. Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkittâs lymphoma. Anticancer Res 1990;10:1183-1187.
Viza D, Vich JM, Phillips J et al. Specific transfer factor protects mice against lethal challenge with herpes simplex virus. Cell Immun 1986;100:555-562.
Wilson GB, Poindexter C, Fort JD et al. De novo initiation of specific cell-mediated immune responsiveness in chickens by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk. ACTA Virol 1988;32:6-18.
Kirkpatrick CH, Hamad AR, and Morton LC. Murine transfer factors: dose-response relationships and routes of administration. Cell Immunol 1995:164:203-206.
Viza D, Lefesvre A, Patrasco M et al. A preliminary report on three AIDS patients treated with anti-HIV specific transfer factor. J Exp Path 1987;3:653-659.
Pizza G, DeVinci C, Palareti A et al. 25 years of clinical experience with transfer factors. XI International Symposium on Transfer Factor. March 1-4, 1999. Monterey, Mexico.